Related Experiment Video
Updated: Feb 17, 2026

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
Published on: September 19, 2025
EU Joint Action: Integrating Palliative Care in the EU Cancer Agenda: Insights From JANE-2
Line Foss1, Augusto Caraceni2, Carlos Centeno3
1Department of Oncology (L.F., B.J.A.L., M.J.H., S.K.), European Palliative Care Research Centre, Oslo University Hospital/Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Background:
Palliative care is inconsistently integrated into European cancer care, with fragmentation in provision, accessibility, and education leading to avoidable suffering and inefficient use of healthcare resources. There is a need to improve this through a Europe-wide initiative, the Joint Action on Networks of Expertise on Cancer (JANE-2), which builds on the earlier JANE initiative. Within JANE-2, one dedicated work package-6 (WP6) focuses specifically on palliative care.
Methods:
JANE-2 spans 42 partners across 26 countries, in a cross-national, co-produced approach. As part of this, palliative care will be systematically appraised, aligned and ultimately transformed through one work package with four distinct tasks including: 1) organization and delivery, 2) digitalized care pathways with patient-reported outcomes, 3) education and competence frameworks, and 4) indicators for monitoring integration, using a "networks-in-networks" model designed for sustainability beyond JANE2.
Outcomes:
These will include scoping reviews, expert consultations, and modular surveys to support cross-country mapping.
Conclusions:
The palliative care work package within JANE-2 will deliver shared standards, pathways, education, and indicators in a sustainable European Network of Expertise that aims to embed palliative care as an inherent component of cancer care.
Related Concept Videos
Patient-centered Care
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Continuing Care
Treatment Resistant Cancers
Interdisciplinary Care: The Health Care Team-II
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
